Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
DexCom Reports Better-Than-Expected Q4 Results: Details
05:50pm, Thursday, 12'th Feb 2026
Here's a look at the details in the report.
Dexcom beats quarterly estimates on strong demand for glucose monitors
04:43pm, Thursday, 12'th Feb 2026
Medical device maker Dexcom beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
04:03pm, Thursday, 12'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results.
Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth?
12:25pm, Tuesday, 10'th Feb 2026
DexCom heads into Q4 earnings with easing G7 issues, improving supply chains and rebounding U.S. new customer starts lifting revenue outlook.
Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics
10:15am, Tuesday, 10'th Feb 2026
Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Allianz Asset Management GmbH Acquires 47,234 Shares of DexCom, Inc. $DXCM
04:00am, Tuesday, 10'th Feb 2026
Allianz Asset Management GmbH increased its stake in shares of DexCom, Inc. (NASDAQ: DXCM) by 84.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securi
AGF Management Ltd. Makes New $657,000 Investment in DexCom, Inc. $DXCM
04:40am, Friday, 06'th Feb 2026
AGF Management Ltd. bought a new position in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. T
DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features
01:35pm, Thursday, 05'th Feb 2026
Dexcom plans a nationwide AI upgrade to Stelo, adding a million-plus food database and smarter insights to improve glucose understanding and wellness goals.
DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Thursday, 05'th Feb 2026
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DexCom (DXCM) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Wednesday, 04'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 04'th Feb 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
08:30am, Wednesday, 04'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users un
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
05:00pm, Thursday, 29'th Jan 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investig
Here's Why DexCom (DXCM) is a Strong Momentum Stock
10:50am, Wednesday, 28'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hussman Strategic Advisors Inc. Takes $2.83 Million Position in DexCom, Inc. $DXCM
05:51am, Wednesday, 28'th Jan 2026
Hussman Strategic Advisors Inc. purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fir
